Skip Navigation

Profile

Barry I. Freedman, M.D.Wake Forest School of Medicine

Doctor Rating

No Rating Available
Why No Ratings?

Barry I. Freedman, M.D.

Section Chief,
Professor,



Clinical Interests

Atherosclerosis, Nephrology, Genetic Factors in Kidney Disease and Diabetes, Kidney Disease, Diabetes, Clinical Nephrology, Hypertension

Contact Information

Returning Patient Appointments: 336-716-4650
Department: 336-716-4650

Insurance Accepted »

Media Medical Expert »

Education & Training

  • B.S., CUNY Brooklyn College, 1980
  • M.D., SUNY Brooklyn College of Medicine, 1984
  • Residency, Internal Medicine, Eastern Virginia Med School, 1987
  • Fellowship, WFU School of Medicine, 1989

Board Certifications

  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Nephrology

Memberships

  • Int'L Society Of Nephrology
  • Nat'L Kidney Foundation
  • North Carolina Medical Assn
  • Renal Physicians Assn
  • Am Coll Of Physicians
  • Am Heart Association
  • Am Soc Of Hypertension
  • Am Soc Of Nephrology
  • Alpha Omega Alpha

NPI Number

  • 1245215672
Barry I. Freedman, M.D.

Doctor Rating

No Rating Available
Why No Ratings?

Barry I. Freedman, M.D.

Section Chief, Nephrology
Professor, Nephrology
Sticht Center on Aging
Institute for Regenerative Medicine
Urology

Research Interests

African Americans; Kidney Failure, Chronic; Diabetes Mellitus, Type 2; Apolipoproteins; Lipoproteins, HDL
More »

Contact Information

Academic: 336-716-4650 | Department: 336-716-4650

Media Medical Expert »

Recent Publications

Efficacy and safety of low-dose heparin in hemodialysis. Murea M, Russell GB, Daeihagh P, Saran AM, Pandya K, Cabrera M, Burkart JM, Freedman BI.. Hemodial Int. 2018;22(1):74-81.

A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy. Skorecki KL, Lee JH, Langefeld CD, Rosset S, Tzur S, Wasser WG, Shemer R, Hawkins GA, Divers J, Parekh RS, Li M, Sampson MG, Kretzler M, Pollak MR, Shah S, Blackler D, Nichols B, Wilmot M, Alper SL, Freedman BI, Friedman DJ.. Nephrol Dial Transplant. 2018;33(2):323-330.

Effects of weight-based ultrafiltration rate limits on intradialytic hypotension in hemodialysis. Pirkle JL Jr, Comeau ME, Langefeld CD, Russell GB, Balderston SS, Freedman BI, Burkart JM.. Hemodial Int. 2018;22(2):270-278.

Blood pressure indices and cardiovascular disease mortality in persons with or without diabetes mellitus. Gomadam P, Shah A, Qureshi W, Yeboah PN [sic] Yeboah PK, Freedman BI, Bowden D, Soliman EZ, Yeboah J.. J Hypertens. 2018;36(1):85-92.

Influence of baseline diastolic blood pressure on effects of intensive compared with standard blood pressure control. Beddhu S, Chertow GM, Cheung AK, Cushman WC, Rahman M, Greene T, Wei G, Campbell RC, Conroy M, Freedman BI, Haley WE, Horwitz EJ, Kitzman DW, Lash J, Papademetriou V, Pisoni R, Riessen E, Rosendorff C, Watnick SG, Whittle J, Whelton PK.. Circulation. 2018;137(2):134-143.

Need to reclassify etiologies of ESRD on the CMS 2728 Medical Evidence Report.. Tucker BM, Freedman BI.. Clin J Am Soc Nephrol. 2018;13(3):477-479.

FGF23 concentration and APOL1 genotype are novel predictors of mortality in African Americans with type 2 diabetes. Chan GC, Divers J, Russell GB, Langefeld CD, Wagenknecht LE, Hsu FC, Xu J, Smith SC, Palmer ND, Hicks PJ, Bowden DW, Register TC, Ma L, Carr JJ, Freedman BI.. Diabetes Care. 2018;41(1):178-186.

Effects of intensive blood pressure treatment on acute kidney injury events in the Systolic Blood Pressure Intervention Trial (SPRINT). Rocco MV, Sink KM, Lovato LC, Wolfgram DF, Wiegmann TB, Wall BM, Umanath K, Rahbari-Oskoui F, Porter AC, Pisoni R, Lewis CE, Lewis JB, Lash JP, Katz LA, Hawfield AT, Haley WE, Freedman BI, Dwyer JP, Drawz PE, Dobre M, Cheung AK,.. Am J Kidney Dis. 2018;71(3):352-361.

The African Descent and Glaucoma Evaluation Study (ADAGES) III: contribution of genotype to glaucoma phenotype in African Americans: study design and baseline data. Zangwill LM, Ayyagari R, Liebmann JM, Girkin CA, Feldman R, Dubiner H, Dirkes KA, Holmann M, Williams-Steppe E, Hammel N, Saunders LJ, Vega S, Sandow K, Roll K, Slight R, Auerbach D, Samuels BC, Panarelli JF, Mitchell JP, Al-Aswad LA,.. Ophthalmology. 2018;():.

Transethnic evaluation identifies low-frequency loci associated with 25-hydroxyvitamin D concentrations. Hong J, Hatchell KE, Bradfield JP, Andrew B, Alessandra C, Chao-Qiang L, Langefeld CD, Lu L, Lu Y, Lutsey PL, Musani SK, Nalls MA, Robinson-Cohen C, Roizen JD, Saxena R, Tucker KL, Ziegler JT, Arking DE, Bis JC, Boerwinkle E, Bottinger EP,.. J Clin Endocrinol Metab. 2018;103(4):1380-1392.

Cerebral structure and cognitive performance in African Americans and European Americans with type 2 diabetes. Hsu FC, Sink KM, Hugenschmidt CE, Williamson JD, Hughes TM, Palmer ND, Xu J, Smith SC, Wagner BC, Whitlow CT, Bowden DW, Maldjian JA, Divers J, Freedman BI.. J Gerontol A Biol Sci Med Sci. 2018;73(3):407-414.

Transcriptional regulatory mechanisms in adipose and muscle tissue associated with composite glucometabolic phenotypes. Langefeld CD, Comeau ME, Sharma NK, Bowden DW, Freedman BI, Das SK.. Obesity (Silver Spring). 2018;26(3):559-569.

JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans. Freedman BI, Kistler AL, Skewes-Cox P, Ganem D, Spainhour M, Turner J, Divers J, Langefeld CD, Murea M, Hicks PJ, Hemal AK, Snipes JA, Zhao L, Abend JR, Lyles DS, Ma L, Skorecki KL.. Nephrol Dial Transplant. 2018;():.

Adipose tissue depot volume relationships with spinal trabecular bone mineral density in African Americans with diabetes. Chan GC, Divers J, Russell GB, Langefeld CD, Wagenknecht LE, Xu J, Smith SC, Bowden DW, Register TC, Carr JJ, Lenchik L, Freedman BI.. PLoS One. 2018;13(1):e0191674.

A large-scale multi-ancestry genome-wide study accounting for smoking behavior identifies multiple significant loci for blood pressure. Sung YJ, Winkler TW, de Las Fuentes L, Bentley AR, Brown MR, Kraja AT, Schwander K, Ntalla I, Guo X, Franceschini N, Lu Y, Cheng CY, Sim X, Vojinovic D, Marten J, Musani SK, Li C, Feitosa MF, Kilpelainen TO, Richard MA, Noordam R, Aslibekyan S,.. Am J Hum Genet. 2018;102(3):375-400.

Characterization of coding/noncoding variants for SHROOM3 in patients with CKD. Prokop JW, Yeo NC, Ottmann C, Chhetri SB, Florus KL, Ross EJ, Sosonkina N, Link BA, Freedman BI, Coppola CJ, McDermott-Roe C, Leysen S, Milroy LG, Meijer FA, Geurts AM, Rauscher FJ III, Ramaker R, Flister MJ, Jacob HJ, Mendenhall EM, Lazar J.. J Am Soc Nephrol. 2018;29(5):1525-1535.

Evaluation of potential living kidney donors in the APOL1 era [editorial]. Freedman BI, Julian BA.. J Am Soc Nephrol. 2018;29(4):1079-1081.

Psoas and paraspinous muscle index as a predictor of mortality in African American men with type 2 diabetes mellitus. Murea M, Lenchik L, Register TC, Russell GB, Xu J, Smith SC, Bowden DW, Divers J, Freedman BI.. J Diabetes Complications. 2018;32(6):558-564.

Predicting mortality in African Americans with type 2 diabetes mellitus: soluble urokinase plasminogen activator receptor, coronary artery calcium, and high-sensitivity C-reactive protein. Hayek SS, Divers J, Raad M, Xu J, Bowden DW, Tracy M, Reiser J, Freedman BI.. J Am Heart Assoc. 2018;7(9):e008194.

Soluble urokinase plasminogen activator receptor compared to coronary artery calcium score and high sensitivity C reactive protein in predicting death in African American with diabetes [abstract]. Raad M, Hayek S, Xu JZ, Bowden D, Reiser D, Freedman B.. J Am Coll Cardiol. 2018;71(11 Suppl):1831.

Associations of coronary artery calcified plaque density with mortality in type 2 diabetes: the Diabetes Heart Study. Raffield LM, Cox AJ, Criqui MH, Hsu FC, Terry JG, Xu J, Freedman BI, Carr JJ, Bowden DW.. Cardiovasc Diabetol. 2018;17(1):67.

Glycated albumin and blood sugar control in advanced chronic kidney disease. Robinson TW, Freedman BI.. Nephrol Dial Transplant. 2018;():.

The APOL1 long-term kidney transplantation outcomes network-APOLLO [editorial]. Freedman BI, Moxey-Mims M.. Clin J Am Soc Nephrol. 2018;13(6):940-942.

Genome-wide interaction with the insulin secretion locus MTNR1B reveals CMIP as a novel type 2 diabetes susceptibility gene in African Americans. Keaton JM, Gao C, Guan M, Hellwege JN, Palmer ND, Pankow JS, Fornage M, Wilson JG, Correa A, Rasmussen-Torvik LJ, Rotter JI, Chen YI, Taylor KD, Rich SS, Wagenknecht LE, Freedman BI, Ng MCY, Bowden DW.. Genet Epidemiol. 2018;():.

Response [to FGF23 concentration and APOL1 genotype are novel predictors of mortality in African Americans with type 2 diabetes] [letter]. Divers J, Freedman BI.. Diabetes Care. 2018;41(5):e79-e80.

APOL1 long-term kidney transplantation outcomes network (APOLLO) [abstract]. Guerra G, Poggio E, Ortigosa-Goggins M, Doshi M, Freedman B, Reboussin D, Kimmel P.. Am J Transplant. 2018;18(Suppl 4):938.

Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions. Langefeld CD, Comeau ME, Ng MCY, Guan M, Dimitrov L, Mudgal P, Spainhour MH, Julian BA, Edberg JC, Croker JA, Divers J, Hicks PJ, Bowden DW, Chan GC, Ma L, Palmer ND, Kimberly RP, Freedman BI.. Kidney Int. 2018;():.

Volumetric bone mineral density of the spine predicts mortality in African-American men with type 2 diabetes. Lenchik L, Register TC, Russell GB, Xu J, Smith SC, Bowden DW, Divers J, Freedman BI.. Osteoporos Int. 2018;():.

Genome-wide association of CKD progression: the chronic renal insufficiency cohort study. Parsa A, Kanetsky PA, Xiao R, Gupta J, Mitra N, Limou S, Xie D, Xu H, Anderson AH, Ojo A, Kusek JW, Lora CM, Hamm LL, He J, Sandholm N, Jeff J, Raj DE, Boger CA, Bottinger E, Salimi S, Parekh RS, Adler SG, Langefeld CD, Bowden DW, Groop PH,.. J Am Soc Nephrol. 2017;28(3):923-934.

Effect of replacing race with apolipoprotein L1 genotype in calculation of kidney donor risk index. Julian BA, Gaston RS, Brown WM, Reeves-Daniel AM, Israni AK, Schladt DP, Pastan SO, Mohan S, Freedman BI, Divers J.. Am J Transplant. 2017;17(6):1540-1548.

APOL1 renal-risk variants induce mitochondrial dysfunction. Ma L, Chou JW, Snipes JA, Bharadwaj MS, Craddock AL, Cheng D, Weckerle A, Petrovic S, Hicks PJ, Hemal AK, Hawkins GA, Miller LD, Molina AJ, Langefeld CD, Murea M, Parks JS, Freedman BI.. J Am Soc Nephrol. 2017;28(4):1093-1105.

APOL1 genotype, blood pressure, and survival in African Americans with nondiabetic nephropathy [commentary]. Robinson TW, Freedman BI.. Kidney Int. 2017;91(2):276-278.

APOL1 gene kidney risk variants and cardiovascular disease: getting to the heart of the matter. McLean NO, Robinson TW, Freedman BI.. Am J Kidney Dis. 2017;70(2):281-289.

A low-frequency inactivating Akt2 variant enriched in the Finnish population is associated with fasting insulin levels and type 2 diabetes risk. Manning A, Highland HM, Gasser J, Sim X, Tukiainen T, Fontanillas P, Grarup N, Rivas MA, Mahajan A, Locke AE, Cingolani P, Pers TH, Vinuela A, Brown AA, Wu Y, Flannick J, Fuchsberger C, Gamazon ER, Gaulton KJ, Im HK, Teslovich TM, Blackwell TW,.. Diabetes. 2017;66(7):2019-2032.

Blood pressure indices and cardiovascular mortality in diabetics and non diabetics [abstract]. Gomadam P, Qureshi W, Shah A, Freedman B, Bowden DW, Soliman E, Yeboah J.. J Am Coll Cardiol. 2017;69(11 Suppl):1849.

Fluid and volume therapy in the ICU. Robinson TW, Freedman BI. In: Vincent JL, Abraham E, Moore FA, Kochanek PM, Fink MP, eds. Textbook of critical care. 7th ed. Philadelphia (PA): Elsevier;2017: 761-765.e1.

Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium. Ng MCY, Graff M, Lu Y, Justice AE, Mudgal P, Liu CT, Young K, Yanek LR, Feitosa MF, Wojczynski MK, Rand K, Brody JA, Cade BE, Dimitrov L, Duan Q, Guo X, Lange LA, Nalls MA, Okut H, Tajuddin SM, Tayo BO, Vedantam S, Bradfield JP, Chen G,.. PLoS Genet. 2017;13(4):e1006719.

Associations of early kidney disease with brain magnetic resonance imaging and cognitive function in African Americans with type 2 diabetes mellitus. Freedman BI, Sink KM, Hugenschmidt CE, Hughes TM, Williamson JD, Whitlow CT, Palmer ND, Miller ME, Lovato LC, Xu J, Smith SC, Launer LJ, Barzilay JI, Cohen RM, Sullivan MD, Bryan RN, Wagner BC, Bowden DW, Maldjian JA, Divers J.. Am J Kidney Dis. 2017;70(5):627-637.

Genetic epidemiology in kidney disease. Ainsworth HC, Langefeld CD, Freedman BI.. Nephrol Dial Transplant. 2017;32(Suppl 2):159-169.

Hepatocyte ABCA1 deletion impairs liver insulin signaling and lipogenesis. Key CC, Liu M, Kurtz CL, Chung S, Boudyguina E, Dinh TA, Bashore A, Phelan PE, Freedman BI, Osborne TF, Zhu X, Ma L, Sethupathy P, Biddinger SB, Parks JS.. Cell Rep. 2017;19(10):2116-2129.

A tripartite complex of suPAR, APOL1 risk variants and alphavbeta3 integrin on podocytes mediates chronic kidney disease. Hayek SS, Koh KH, Grams ME, Wei C, Ko YA, Li J, Samelko B, Lee H, Dande RR, Lee HW, Hahm E, Peev V, Tracy M, Tardi NJ, Gupta V, Altintas MM, Garborcauskas G, Stojanovic N, Winkler CA, Lipkowitz MS, Tin A, Inker LA, Levey AS, Zeier M, Freedman BI,.. Nat Med. 2017;23(8):945-953.

Effects of intensive BP control in CKD. Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, Cushman WC, Hawfield AT, Johnson KC, Lewis CE, Oparil S, Rocco MV, Sink KM, Whelton PK, Wright JT Jr, Basile J, Beddhu S, Bhatt U, Chang TI, Chertow GM, Chonchol M,.. J Am Soc Nephrol. 2017;28(9):2812-2823.

Adiponectin isoform patterns in ethnic-specific ADIPOQ mutation carriers: the IRAS Family Study. Tabb KL, Gao C, Hicks PJ, Hawkins GA, Rotter JI, Chen YI, Guo X, Norris JM, Lorenzo C, Freedman BI, Bowden DW, Palmer ND.. Obesity (Silver Spring). 2017;25(8):1384-1390.

Type 2 diabetes variants disrupt function of SLC16A11 through two distinct mechanisms. Rusu V, Hoch E, Mercader JM, Tenen DE, Gymrek M, Hartigan CR, DeRan M, von Grotthuss M, Fontanillas P, Spooner A, Guzman G, Deik AA, Pierce KA, Dennis C, Clish CB, Carr SA, Wagner BK, Schenone M, Ng MCY, Chen BH, Centeno-Cruz F, Zerrweck C,.. Cell. 2017;170(1):.

APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial. Freedman BI, Rocco MV, Bates JT, Chonchol M, Hawfield AT, Lash JP, Papademetriou V, Sedor JR, Servilla K, Kimmel PL, Wall BM, Pajewski NM.. Kidney Int Rep. 2017;2(4):713-720.

Transancestral mapping and genetic load in systemic lupus erythematosus. Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlof JC, Acevedo-Vasquez EM, Alarcon GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA,.. Nat Commun. 2017;8():16021.

Effects of intensive systolic blood pressure control on kidney and cardiovascular outcomes in persons without kidney disease: a secondary analysis of a randomized trial. Beddhu S, Rocco MV, Toto R, Craven TE, Greene T, Bhatt U, Cheung AK, Cohen D, Freedman BI, Hawfield AT, Killeen AA, Kimmel PL, Lash J, Papademetriou V, Rahman M, Rastogi A, Servilla K, Townsend RR, Wall B, Whelton PK.. Ann Intern Med. 2017;167(6):375-383.

Genetic regulation of adipose tissue transcript expression is involved in modulating serum triglyceride and HDL-cholesterol. Sajuthi SP, Sharma NK, Comeau ME, Chou JW, Bowden DW, Freedman BI, Langefeld CD, Parks JS, Das SK.. Gene. 2017;632():50-58.

Effect of intensive blood-pressure treatment on patient-reported outcomes. Berlowitz DR, Foy CG, Kazis LE, Bolin LP, Conroy MB, Fitzpatrick P, Gure TR, Kimmel PL, Kirchner K, Morisky DE, Newman J, Olney C, Oparil S, Pajewski NM, Powell J, Ramsey T, Simmons DL, Snyder J, Supiano MA, Weiner DE, Whittle J, Rocco M,.. N Engl J Med. 2017;377(8):733-744.

Vascular access placement order and outcomes in hemodialysis patients: a longitudinal study. Murea M, Brown WM, Divers J, Moossavi S, Robinson TW, Bagwell B, Burkart JM, Freedman BI.. Am J Nephrol. 2017;46(4):268-275.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Nephrology

Clinical Interests

Atherosclerosis, Nephrology, Genetic Factors in Kidney Disease and Diabetes, Kidney Disease, Diabetes, Clinical Nephrology, Hypertension
Barry I. Freedman, M.D.

Barry I. Freedman, M.D.

Section Chief, Nephrology
Professor, Nephrology
Sticht Center on Aging
Institute for Regenerative Medicine
Urology

CP concern for questions/worries
5
CP efforts to include in decisions
5
CP explanations of prob/condition
5
CP spoke using clear language
5
Friendliness/courtesy of CP
5
Likelihood of recommending CP
5
Patients' confidence in CP
5
Time CP spent with patient
5
Wait time at clinic
5

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.